Abridge raises $30M to Accelerate Adoption of its Proven Generative AI Solution across U.S. Healthcare Systems
Abridge , the leader in generative AI for clinical documentation, announced a Series B raise of $30 million, led by Spark Capital.
- Abridge , the leader in generative AI for clinical documentation, announced a Series B raise of $30 million, led by Spark Capital.
- This investment will support large-scale health system rollouts and accelerate product advances that will create additional value for patients, clinicians, and health systems.
- View the full release here: https://www.businesswire.com/news/home/20231026850279/en/
“Spark Capital is proud to lead this industry-defining investment in Abridge,” said Will Reed, a General Partner at Spark Capital focused on growth stage AI investments. - The solution has been uniquely designed with trust and auditability, providing the ability to quickly see source data from any AI-generated summary.